Together with GSK3β, Fbxw7 controls the turnover of a number of key oncogenes such as c-Myc, Cyclin E and NOTCH (26–30) and has emerged as an important tumour suppressor that is frequently mutated in cancer (31). Here, FBXW7 is linked to cancer.